FDA, FTC File Joint Complaint for Injunction Against Makers of Herbal Tea Marketed as COVID-19 Cure
March 30, 2022 at 08:15 PM EST
In a joint enforcement action that may serve as a model for future action targeting noncompliant marketing by dietary supplement manufacturers, the FDA and the Federal Trade Commission (FTC) alleged in a complaint filed in a federal district court in Brooklyn, New York, that the makers of an herbal tea product touted as a treatment for COVID-19 violated provisions of the Feder... Read More
